Evelo Biosciences Announces Positive Phase 2 Clinical Data with EDP1815 in Psoriasis; Confirms Ability to Harness the Small Intestinal Axis, SINTAX(TM), to Treat Systemic Inflammatory Disease

Stock Information for Evelo Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.